Topic

North Carolina

A collection of 452 issues

Get Voydeya (Danicopan) Approved by UnitedHealthcare in North Carolina: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting Voydeya Covered by UnitedHealthcare in North Carolina Voydeya (danicopan) requires prior authorization from UnitedHealthcare for coverage as an add-on therapy to C5 inhibitors (eculizumab or ravulizumab) in adults with paroxysmal nocturnal hemoglobinuria (PNH) experiencing extravascular hemolysis. Your fastest path to approval: Have your hematologist submit a prior
7 min read

How to Get Lumizyme (Alglucosidase Alfa) Covered by Humana in North Carolina: Prior Authorization, Appeals, and Success Strategies

Answer Box: Getting Lumizyme Covered by Humana in North Carolina Lumizyme (alglucosidase alfa) requires prior authorization from Humana for Pompe disease patients in North Carolina. Success depends on three critical elements: (1) confirmed GAA enzyme deficiency plus genetic testing showing two pathogenic GAA gene variants, (2) prescription from a qualified
6 min read

How to Get Cosentyx (Secukinumab) Covered by UnitedHealthcare in North Carolina: Appeals Guide & Success Strategies

Answer Box: Getting Cosentyx Covered by UnitedHealthcare in North Carolina UnitedHealthcare requires prior authorization for Cosentyx (secukinumab) with specific documentation of treatment failures and medical necessity. The fastest path: Have your dermatologist or rheumatologist submit a complete PA request with detailed records of failed first-line therapies. If denied, you have
6 min read

How to Get Besponsa (Inotuzumab Ozogamicin) Covered by Humana in North Carolina: Complete Guide to Prior Authorization, Appeals, and Billing Codes

Answer Box: Getting Besponsa Covered by Humana in North Carolina Besponsa (inotuzumab ozogamicin) requires prior authorization through Evolent/New Century Health for all Humana Medicare Advantage plans. Submit requests via their portal at my.newcenturyhealth.com or call 844-926-4528 (option 5). Required documentation includes CD22-positive B-cell ALL diagnosis (ICD-10: C91.
6 min read